german cost agency changes tack on alzheimer's drug
germany's healthcare cost-effectiveness watchdog iqwig said alzheimer's disease drug memantine provides a benefit, one and a half years after its initial rejection.
http://feeds.reuters.com/~r/reuters/healthnews/~3/fj6dhudhi4q/us-germany-memantine-idustre73p5xe20110426
21372
26 Apr 2011 20:50:35
reuters
health